These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32838584)

  • 41. Human papillomavirus vaccine: the beginning of the end for cervical cancer.
    Bornstein J
    Isr Med Assoc J; 2007 Mar; 9(3):156-8. PubMed ID: 17402325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
    Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
    AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antiviral activity of extracts of basidiomycetes and humic compounds substances against Human Immunodeficiency Virus (Retroviridae: Orthoretrovirinae: Lentivirus: Human immunodeficiency virus 1) and Herpes Simplex Virus (Herpesviridae: Simplexvirus: Human alphaherpesvirus 1)].
    Nosik DN; Nosik NN; Teplyakova TV; Lobach OA; Kiseleva IA; Kondrashina NG; Bochkova MS; Ananko GG
    Vopr Virusol; 2020 Nov; 65(5):276-283. PubMed ID: 33533211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of the Herpes Simplex Virus 2 (HSV-2) Glycoprotein D/AS04 Vaccine against Genital HSV-2 and HSV-1 Infection and Disease in the Cotton Rat Sigmodon hispidus Model.
    Boukhvalova M; McKay J; Mbaye A; Sanford-Crane H; Blanco JC; Huber A; Herold BC
    J Virol; 2015 Oct; 89(19):9825-40. PubMed ID: 26178984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topical microbicides for prevention of sexually transmitted infections.
    Obiero J; Mwethera PG; Wiysonge CS
    Cochrane Database Syst Rev; 2012 Jun; (6):CD007961. PubMed ID: 22696373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Vertical trasmission of human immunodeficiency virus (HIV) and other sexually transmitted infections (STI)].
    Casalini C; Signorini L; Beltrame A; Matteelli A; Carosi G
    Minerva Ginecol; 2001 Jun; 53(3):177-92. PubMed ID: 11395690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses.
    Kim SH; Samal SK
    Vaccine; 2017 Jul; 35(33):4133-4139. PubMed ID: 28668574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sexual transmission of hepatitis B in Mwanza, Tanzania.
    Jacobs B; Mayaud P; Changalucha J; Todd J; Ka-Gina G; Grosskurth H; Berege ZA
    Sex Transm Dis; 1997 Mar; 24(3):121-6. PubMed ID: 9132977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.
    Zhang Z; Dong Z; Li J; Carr MJ; Zhuang D; Wang J; Zhang Y; Ding S; Tong Y; Li D; Shi W
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28424287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Viral sexually transmitted infections: prevention, treatments and perspectives].
    Nikolic DS; Piguet V
    Rev Med Suisse; 2010 Apr; 6(246):866-70. PubMed ID: 20455384
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progress in the development of virus-like particle vaccines against respiratory viruses.
    Quan FS; Basak S; Chu KB; Kim SS; Kang SM
    Expert Rev Vaccines; 2020 Jan; 19(1):11-24. PubMed ID: 31903811
    [No Abstract]   [Full Text] [Related]  

  • 53. Prevalence of sexually transmitted infections (HIV, hepatitis B virus, herpes simplex virus type 2, and syphilis) in pregnant women in Ethiopia: Trends over 10 years (2005-2014).
    Kassa D; Gebremichael G; Tilahun T; Ayalkebet A; Abrha Y; Mesfin G; Belay Y; Demissie M; Gebrexiabher A; Assefa Y
    Int J Infect Dis; 2019 Feb; 79():50-57. PubMed ID: 30472433
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Update on the epidemiology, diagnosis and treatment of sexually-transmitted infections].
    Lepe Jiménez JA; Otero Guerra L; Blanco Galán MA; Aznar Martín J; Vázquez Valdés F
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 13():25-31. PubMed ID: 19100164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The theoretical impact and cost-effectiveness of vaccines that protect against sexually transmitted infections and disease.
    Garnett GP
    Vaccine; 2014 Mar; 32(14):1536-42. PubMed ID: 24606635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV Universal Vaccine.
    Malecki M; Saetre B
    Mol Cell Ther; 2018 Apr; 6(1):. PubMed ID: 30815266
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tumour virus vaccines: hepatitis B virus and human papillomavirus.
    Stanley M
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of Human Papillomavirus, Human Immunodeficiency Virus, and Other Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo: A National Cross-sectional Survey.
    Ferré VM; Gbeasor-Komlanvi FA; Collin G; Dagnra AC; Le Hingrat Q; Jaquet A; Salou M; Descamps D; Charpentier C; Ekouevi DK
    Clin Infect Dis; 2019 Aug; 69(6):1019-1026. PubMed ID: 30520971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
    Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ; Morrison LA; Knipe DM
    Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.